PRDM5 and neoplasm: To determine whether promoter methylation directly contributes to PRDM5 silencing, several silenced tumor cell lines were treated with DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine (Aza) alone or combined with histone deacetylase inhibitor trichostatin A (TSA).